Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pliant Therapeutics
Biotech
Pliant cuts workforce by 45% after bexotegrast trial safety woes
Pliant announced that it will be cutting 45% of staffers as part of a “strategic restructuring of its workforce.”
Ben Adams
May 2, 2025 7:33am
Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms
Mar 14, 2025 10:01am
Pliant terminates lung disease trial due to adverse events
Mar 3, 2025 11:30am
Pliant pauses lung fibrosis trial on advice of safety committee
Feb 10, 2025 4:18am
Flagship vet plants CEO roots at Pharming—Chutes & Ladders
Jan 24, 2025 8:30am
Pliant liver disease med passes high-dose test but doesn't wow
Feb 5, 2024 10:40am
